The new WHOOP MG offers real-time ECG scans, AI coaching, and blood pressure tracking, but the company's FDA clash could ...

The company’s Whoop MG is the subject of a disagreement with the US Food and Drug Administration (FDA) over whether it acts ...

The Boston wearables firm says the software tool doesn't meet the definition of a medical device and shouldn't be regulated ...

The Whoop MG is the company's latest display-less tracker, but a recent report states it's in hot water with the FDA.

The Whoop MG launched in May with a novel Blood Pressure Insights feature. Now, the FDA wants the company to disable it.

The company's CEO defended its feature as a wellness tool under the 21st Century Cures Act, combating the FDA’s claim that it qualifies as a regulated medical device.

In response, Whoop pulled out the W word: wellness.

Scott Kirsner, a columnist from our editorial partner MassLive, joins WBUR's Morning Edition to discuss the feud.

Despite the FDA’s requests to remove the blood pressure tracking tool in Whoop’s new fitness tracker, the company has ...

The FDA’s warning letter to Whoop Inc. resurrects questions about the agency’s observance of the 21st Century Cures Act in ...